Takeda Pharmaceutical Company Limited (TAK) Social Stream
Takeda Pharmaceutical Co Ltd (TAK) Price Targets From Analysts
Use the tables below to see what analysts covering Takeda Pharmaceutical Co Ltd think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 15 months, TAK's average price target has gone down $6.89.
TAK reports an average of 27.09% for its upside potential over the past 126 days.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
TAK Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 28 days, TAK's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, Takeda Pharmaceutical Co Ltd's number of analysts covering the stock is greater than 66.9% of them.
- To contextualize these metrics, consider that out of stocks in the large market cap category, Takeda Pharmaceutical Co Ltd's average analyst price target is greater than 44.37% of them.
- Takeda Pharmaceutical Co Ltd's upside potential (average analyst target price relative to current price) is greater than 71.07% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Takeda Pharmaceutical Co Ltd's variance in analysts' estimates is lower than -29.87% of them.
What is the outlook for TAK? Use POWR Ratings for clearer insight into price direction.